US4158056A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antiviral method
Assignee: Eli Lilly and Co
•
Filing: 1978-07-13
•
Granted: 1979-06-12
•
Expires: 1998-07-13
Abstract
Abstract 5'-Deoxy-5'-(1,4-diamino-4-carboxybutyl)adenosine, also known as Sinefungin and as antibiotic A-9145, is employed in a method for treating and controlling viral infections, for example, Herpes simplex and Pseudorabies infections in man and animals.
Inventors
- 👤 Ramakrishnan Nagarajan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 17:50
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/16
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
46 words
A method of controlling a virus infection in a mammal suffering from a virus infection wherein the virus is Herpes simplex or Pseudorabies which comprises administering to said mammal an antiviral effective amount of antibiotic A-9145 of the formula ##STR2## or a pharmaceutically acceptable salt thereof.
Claim 2
Independent Claim
46 words
A method of controlling a virus infection in a mammal suffering from a virus infection wherein the virus is Herpes simplex or Pseudorabies which comprises administering to said mammal an antiviral effective amount of antibiotic A-9145 of the formula ##STR2## or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
14 words
The method of claim 1 wherein the virus is Herpes simplex virus Type I.
Claim 4
Dependent Claim
14 words
The method of claim 1 wherein the virus is Herpes simplex virus Type II.
Claim 5
Dependent Claim
11 words
The method of claim 1 wherein the antibiotic is administered topically.
Claim 6
Dependent Claim
15 words
The method of claim 4 wherein the antibiotic in a pharmaceutically acceptable carrier is administered.
Claim 7
Dependent Claim
11 words
The method of claim 1 wherein the antibiotic is administered parenterally.
Claim 8
Dependent Claim
15 words
The method of claim 6 wherein the antibiotic in a pharmaceutically acceptable carrier is administered.
Claim 9
Dependent Claim
11 words
The method of claim 1 wherein the virus is Pseudorabies virus.
Claim 10
Dependent Claim
18 words
The method of claim 8 wherein the antibiotic in a pharmaceutically acceptable carrier is administered topically or parenterally.
References Cited (Backward Citations)
US3758681A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-06-11 | 1982-12-11 | 1983-06-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-06-11 | 1986-12-11 | 1987-06-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-06-11 | 1990-12-11 | 1991-06-12 | $7700.00 | Window Closed / Lapsed |